Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors.
Saved in:
| Title: | Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors. |
|---|---|
| Authors: | Song J; The Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China., Li L; The Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China., Ding L; The Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China., Yang F; The Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China., Mao H; The Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China., Wang K; Department of Neurosurgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China., Li Q; Department of Neurosurgery, The Second Hospital of Lanzhou University, Lanzhou, Gansu, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1796402. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
